Skip to content
healthcare.dev
Get a free key

Melange combination

NDC 62106-1235, Calcarea sulphurica, Calcium phosphoricum, Kali muriaticum, Kalium phosphoricum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, Natrium sulfuricum, Calcarea fluorica, Ferrum phosphoricum, Silicea, tablet, from Seroyal USA.

Product NDC
62106-1235
Status
Listed
Labeler
Seroyal USA
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62106-1235 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS6 [hp_X]/1
  • POTASSIUM CHLORIDE6 [hp_X]/1
  • POTASSIUM PHOSPHATE, DIBASIC6 [hp_X]/1
  • CALCIUM SULFATE ANHYDROUS6 [hp_X]/1
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE6 [hp_X]/1
  • SILICON DIOXIDE12 [hp_X]/1
  • POTASSIUM SULFATE6 [hp_X]/1
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE6 [hp_X]/1
  • SODIUM CHLORIDE6 [hp_X]/1
  • SODIUM SULFATE6 [hp_X]/1
  • CALCIUM FLUORIDE12 [hp_X]/1
  • FERROSOFERRIC PHOSPHATE12 [hp_X]/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
62106-1235-2621061235021 BOTTLE, GLASS in 1 BOX (62106-1235-2) / 100 TABLET in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62106-1235 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62106-1235 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62106-1235. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.